Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Brown & Brown heads into its October 26 earnings report carrying a 15% monthly decline, a fresh wave of analyst target cuts, and options positioning that leans more bullish than fearful.
The most active story this week is on the Street. Three firms lowered their price targets in the space of 48 hours, though none changed their ratings. Mizuho's Yaron Kinar trimmed his target to $78 from $83 but kept Outperform. Barclays cut to $71 from $76, holding Equal-Weight. Morgan Stanley lowered to $55 from $60, staying Underweight. The direction of travel is clearly downward on targets, even if conviction on ratings has not shifted. JP Morgan briefly offered the counterpoint, raising its target to $83 from $80 on October 1, but that now looks like an outlier. The mean target across the analyst group is $75.06, which is 23% above the current price of $60.97. That gap implies the Street still sees meaningful upside, but it has been shrinking with each successive trim.
The bull and bear debate centres on familiar fault lines. Bulls point to pricing gains of 5% to 10% expected in casualty and commercial auto, and to the Specialty Distribution segment's exposure to Florida's expanding excess and surplus lines market, which accounts for more than 20% of revenues. Bears focus on the collapse in commercial property premiums, which fell 39% in Q4 against a 46% drop in Q3, and on lower investment income projections now that rates are easing and the Accession deal cash is no longer on the balance sheet. On forward earnings growth, BRO ranks in the 91st percentile across the universe, a striking figure given how far the stock has fallen. The price-to-earnings multiple has compressed sharply, down more than 2 points over the past month to 12.9x, which is low for a franchise of this quality. The dividend score ranks in the 98th percentile, though the dividend history in the data is stale and should not be relied upon for the current yield figure.
Positioning in the lending market gives little away. Short interest is running at 3.8% of the free float, down roughly 7% from its late-September peak and off 4% over the past month. Borrow remains cheap at 0.52%, up around 18% on the week but still well within the low range. Availability is exceptionally loose at 551%, meaning there are more than five shares available to borrow for every share already shorted. That level has eased noticeably from the 52-week tightest reading of 291%, suggesting the lending market is if anything becoming more relaxed, not more pressured. Options tell a similar story. The put/call ratio is running at 0.33, modestly below its 20-day average of 0.38 and 0.7 standard deviations to the bullish side of that average. This is far from the defensive posture one might expect given the stock's recent slide. For context, the PCR ran above 0.48 through most of August and early September before dropping sharply in late September. The shift toward calls, even as the stock was falling, suggests at least some investors were positioning for a bounce rather than adding further downside protection.
Ownership is notable for one number. The Brown family remains the anchor, with J. Brown holding approximately 11.3% of shares as of March. Among institutional names, State Street added 738,000 shares in the quarter to September 30, the largest disclosed addition among top holders. FMR and First Eagle both added material positions in the July reporting period, 1.55 million and 2.9 million shares respectively. Orbis Investment Management reported a fresh position of 5.37 million shares as of June. None of the 13D/G filers carry activist intent: Vanguard, Capital World and FMR are all passive disclosures. The Vanguard Group filed a 13G/A in March showing its stake had fallen to zero from 11.31%, which is a large outflow, though a separate Vanguard Capital Management entity subsequently disclosed 6.42% in April, suggesting internal restructuring rather than an exit.
Earnings reactions over the past year offer an interesting backdrop. The two most recent prints produced one-day gains of 7.4% and 8.9% respectively, both followed by further gains over the subsequent five days. The one prior to those moved the stock down 3.9% on the day before recovering. That pattern, two strong positive reactions in a row, means the market has rewarded BRO for delivering on its numbers. With the stock now 15% lower on the month and the PCR tilting toward calls, the setup into October 26 is less about whether bears have built a meaningful short position and more about whether the Street's trimmed targets reflect sufficiently reduced expectations for the print to clear the bar.
See the live data behind this article on ORTEX.
Open BRO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.